FYI - For Your Innovation cover image

Shaping the Immunotherapy Landscape with Patrick Hwu, MD

FYI - For Your Innovation

00:00

The Challenge of Persistence in Immunotherapy

The challenge of persistence has been one that we've heard a lot about this year. With targeted therapies and chemotherapies, as soon as those therapies are out of the body, they're not working anymore. The advantage of immunotherapy is these activated immune cells, T cells and other cells can live in the body for decades. And once you activate them, you can get long-term durable responses.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app